Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Nektar Shares Continues Rise on Upgrades Shares of Nektar Therapeutics remained active Wednesday following upgrades from two investment firms after drug giant Pfizer Inc. cited its inhalable insulin product in a recent pipeline report.
